Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial

Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page adds a note about PubMed auto-filled publications and updates the revision tag from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:35:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A funding/operating status notice was removed from the page. No trial content or functionality appears to be changed.
    Difference
    0.4%
    Check dated 2025-11-17T17:18:04.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The new screenshot shows cosmetic UI/layout changes to the study page, with no changes to core study information such as eligibility criteria, outcomes, or enrollment.
    Difference
    0.4%
    Check dated 2025-11-03T09:52:54.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Core status messaging updated and version bumped to v3.2.0; previous v3.1.0 reference removed.
    Difference
    6%
    Check dated 2025-10-05T14:26:40.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.7%
    Check dated 2025-09-28T09:48:32.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision bumped to v3.0.2; the previous v3.0.1 entry is removed and the Back to Top element has been deleted.
    Difference
    0.4%
    Check dated 2025-09-14T00:17:01.000Z thumbnail image

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.